Cat. #157982
DLKP-SQ Mitox MDR cell line
Cat. #: 157982
Sub-type: Continuous
Unit size: 1x10^6 cells / vial
Availability: 8-10 weeks
Organism: Human
Tissue: Lymph Node
Disease: Cancer
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Martin Clynes
Institute: Dublin City University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: DLKP-SQ Mitox MDR cell line
- Cancer: Lung cancer
- Cancers detailed: Lung carcinoma
- Research fields: Cancer;Drug development
- Tool sub type: Continuous
- Parental cell: DLKP-SQ
- Organism: Human
- Tissue: Lymph Node
- Disease: Cancer
- Growth properties: monolayer
- Description: Sub type of lung carcinoma. Squamous sub-population, MDR over-expressing model
- Production details: DLKP-SQ resistant variant. Made resistant to mitoxanthrone, developed MDR1 overexpression.
- Biosafety level: 1
- Recommended controls: DLKP-SQ parental line
Applications
- Application notes: Squamous sub-population, MDR over-expressing model
Handling
- Format: Frozen
- Growth medium: DMEM/Ham's F12, 5% FCS. Split 1:5, medium change 2-3 times weekly. Freezing method: 10% DMSO in FBS
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Storage conditions: Liquid Nitrogen
- Mycoplasma free: Yes
